StockData
ArriVent BioPharma, Inc. logo

ArriVent BioPharma, Inc. (AVBP) stock

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$10.90+0.21 (+1.96%)

Close on Nov 18, 2026Market cap $537.45MP/E –Yield –

ArriVent BioPharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for ArriVent BioPharma

ArriVent BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ArriVent BioPharma figures

See a number that looks wrong?